Shields JA, Shields CL. Intraocular Tumors: A Text and Atlas. Saunders; 1992.

Diener-West M, Earle J, Fine S, Hawkins B, Moy C, Reynolds S, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17. Arch Ophthalmol. 2001;119:951–65.

Article  CAS  PubMed  Google Scholar 

Group TCOMS. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings: COMS Report No. 18. Arch Ophthalmol. 2001;119:969–82.

Article  Google Scholar 

Ghassemi F, Sheibani S, Arjmand M, Poorbaygi H, Kouhestani E, Sabour S, et al. Comparison of iodide-125 and ruthenium-106 brachytherapy in the treatment of choroidal melanomas. Clin Ophthalmol. 2020;14:339–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mairani A, Mein S, Blakely E, Debus J, Durante M, Ferrari A, et al. Roadmap: helium ion therapy. Phys Med Biol. 2022;67:15TR02.

Char DH, Phillips T, Daftari I. Proton teletherapy of uveal melanoma. Int Ophthalmol Clin. 2006;46:41–49.

Article  PubMed  Google Scholar 

Tommasino F, Scifoni E, Durante M. New ions for therapy. Int J Part Ther. 2016;2:428–38.

Article  PubMed  PubMed Central  Google Scholar 

Damato BE. Treatment selection for uveal melanoma. Dev Ophthalmol. 2012;49:16–26.

Article  PubMed  Google Scholar 

Zemba M, Dumitrescu OM, Gheorghe AG, Radu M, Ionescu MA, Vatafu A, et al. Ocular complications of radiotherapy in uveal melanoma. Cancers. 2023;15:333.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allen AM, Pawlicki T, Dong L, Fourkal E, Buyyounouski M, Cengel K, et al. An evidence based review of proton beam therapy: the report of ASTRO’s emerging technology committee. Radiother Oncol. 2012;103:8–11.

Article  PubMed  Google Scholar 

Park JM, Kim JI, Wu HG. Technological advances in charged-particle therapy. Cancer Res Treat. 2021;53:635–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harbour JW, Char DH, Kroll S, Quivey JM, Castro J. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma. Ophthalmology. 1997;104:1785–92.

Article  CAS  PubMed  Google Scholar 

Lin AJ, Rao YJ, Acharya S, Schwarz J, Rao PK, Grigsby P. Patterns of care and outcomes of proton and eye plaque brachytherapy for uveal melanoma: review of the national cancer database. Brachytherapy. 2017;16:1225–31.

Article  PubMed  Google Scholar 

Char DH, Kroll S, Phillips TL, Quivey JM. Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapy. Ophthalmology. 2002;109:1850–4.

Article  PubMed  Google Scholar 

Char DH, Quivey JM, Castro JR, Kroll S, Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology. 1993;100:1547–54.

Article  CAS  PubMed  Google Scholar 

Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:Ed000142.

PubMed  Google Scholar 

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.

Article  PubMed  PubMed Central  Google Scholar 

Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. Joanna briggs institute reviewer’s manual, vol 5. The Joanna Briggs Institute; 2021. pp. 217–69.

Mishra KK, Quivey JM, Daftari IK, Weinberg V, Cole TB, Patel K, et al. Long-term results of the UCSF-LBNL randomized trial: charged particle with helium ion versus iodine-125 plaque therapy for choroidal and ciliary body melanoma. Int J Radiat Oncol Biol Phys. 2015;92:376–83.

Article  PubMed  Google Scholar 

Bolling JP, Dagan R, Rutenberg M, Mamalui-Hunter M, Buskirk SJ, Heckman MG, et al. Treatment of uveal melanoma with radioactive iodine 125 implant compared with proton beam radiotherapy. Mayo Clin Proc Innov Qual Outcomes. 2022;6:27–36.

Article  PubMed  Google Scholar 

Wilson MW, Hungerford JL. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology. 1999;106:1579–87.

Article  CAS  PubMed  Google Scholar 

Kowal J, Markiewicz A, Dębicka-Kumela M, Bogdali A, Jakubowska B, Karska-Basta I, et al. Analysis of local recurrence causes in uveal melanoma patients treated with (125)I brachytherapy - a single institution study. J Contemp Brachytherapy. 2019;11:554–62.

Article  PubMed  PubMed Central  Google Scholar 

Oxenreiter MM, Lane AM, Aronow MB, Shih H, Trofimov AV, Kim IK, et al. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field). Br J Ophthalmol. 2022;106:518–21.

Article  PubMed  Google Scholar 

Hussain RN, Chiu A, Pittam B, Taktak A, Damato BE, Kacperek A, et al. Proton beam radiotherapy for choroidal and ciliary body melanoma in the UK-national audit of referral patterns of 1084 cases. Eye. 2022;37:1033–6.

Article  PubMed  PubMed Central  Google Scholar 

Guleser UY, Sarici AM, Ucar D, Gonen B, Sengul Samanci N, Özgüroğlu M. Comparison of iodine-125 plaque brachytherapy and gamma knife stereotactic radiosurgery treatment outcomes for uveal melanoma patients. Graefes Arch Clin Exp Ophthalmol. 2022;260:1337–43.

Article  CAS  PubMed  Google Scholar 

Mazzini C, Pieretti G, Vicini G, Nicolosi C, Scoccianti S, Pertici M, et al. Clinical outcomes and secondary glaucoma after gamma-knife radiosurgery and Ruthenium-106 brachytherapy for uveal melanoma: a single institution experience. Melanoma Res. 2021;31:38–48.

Article  CAS  PubMed  Google Scholar 

Cennamo G, Montorio D, D’Andrea L, Farella A, Matano E, Giuliano M, et al. Long-term outcomes in uveal melanoma after ruthenium-106 brachytherapy. Front Oncol. 2021;11:754108.

Article  CAS  PubMed  Google Scholar 

Hauzinger JA, Blatsios G, Haas G, Zehetner C, Velez-Escola L, Nowosielski Y, et al. Proton beam radiation for iris melanoma: case series and review of literature. BMJ Open Ophthalmol. 2021;6:e000683.

Article  PubMed  PubMed Central  Google Scholar 

Fili M, Astrahan M, Stålhammar G. Long-term outcomes after enucleation or plaque brachytherapy of choroidal melanomas touching the optic disc. Brachytherapy. 2021;20:1245–56.

Article  PubMed  Google Scholar 

Sobti MM, Edington M, Connolly J, McLernon DJ, Schipani S, Ritchie D, et al. Outcomes following notched ruthenium-106 plaque brachytherapy for juxtapapillary choroidal melanomas. Ocul Oncol Pathol. 2021;7:411–7.

Article  PubMed  PubMed Central  Google Scholar 

Marinkovic M, Pors LJ, van den Berg V, Peters FP, Schalenbourg A, Zografos L, et al. Clinical outcomes after international referral of uveal melanoma patients for proton therapy. Cancers. 2021;13:6241.

Article  PubMed  PubMed Central  Google Scholar 

Meidenbauer K, Richards Z, Yupari RJ, Bena JF, Wilkinson A, Suh J, et al. Outcomes for posterior uveal melanoma: validation of american brachytherapy society guidelines. Brachytherapy. 2021;20:1226–34.

Article  PubMed  Google Scholar 

Zhou N, Zhang R, Liu Y, Wei W. Clinical characteristics of UM and association of metastasis of uveal melanoma with congenital oculocutaneous melanosis in asian patients: analysis of 1151 consecutive eyes. Ophthalmol Retina. 2021;5:1164–72.

Article  PubMed  Google Scholar 

Yupari RJ, Bena J, Wilkinson A, Suh J, Singh A. Small choroidal melanoma: outcomes following apical height dose brachytherapy. Br J Ophthalmol. 2021;105:1161–5.

Article  PubMed  Google Scholar 

Xu TT, Pulido JS, Deufel CL, Corbin KS, Petersen IA, Dalvin LA. Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma. Eye. 2021;35:2754–62.

Article  PubMed  Google Scholar 

Jampol LM, Moy CS, Murray TG, Reynolds SM, Albert DM, Schachat AP, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS Report No. 19. Ophthalmology. 2020;127:S148–s157.

Article  PubMed  Google Scholar 

Jung SK, Park YH, Shin DH, Kim HS, Jung JH, Kim TH, et al. Visual outcomes of proton beam therapy for choroidal melanoma at a single institute in the Republic of Korea. PLoS ONE. 2020;15:e0242966.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Filì M, Trocme E, Bergman L, See TRO, André H, Bartuma K, et al. Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm. Br J Ophthalmol. 2020;104:26–32.

Article  PubMed  Google Scholar 

Jiang P, Purtskhvanidze K, Kandzia G, Neumann D, Luetzen U, Siebert FA, et al. (106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma. Radiat Oncol. 2020;15:183.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riechardt AI, Stroux A, Seibel I, Heufelder J, Zeitz O, Böhmer D, et a